[go: up one dir, main page]

CN103720740A - Gynostemma pentaphylla extract and fungus transformation preparation method thereof - Google Patents

Gynostemma pentaphylla extract and fungus transformation preparation method thereof Download PDF

Info

Publication number
CN103720740A
CN103720740A CN201410019158.3A CN201410019158A CN103720740A CN 103720740 A CN103720740 A CN 103720740A CN 201410019158 A CN201410019158 A CN 201410019158A CN 103720740 A CN103720740 A CN 103720740A
Authority
CN
China
Prior art keywords
extract
gynostemma
gynostemma pentaphyllum
ethanol
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410019158.3A
Other languages
Chinese (zh)
Inventor
朴香兰
金玉兰
曲田丽
刘慧敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Minzu University of China
Original Assignee
Minzu University of China
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minzu University of China filed Critical Minzu University of China
Priority to CN201410019158.3A priority Critical patent/CN103720740A/en
Publication of CN103720740A publication Critical patent/CN103720740A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

本发明涉及一种绞股蓝提取物及其真菌转化制备方法,该提取物的制备方法是:取绞股蓝乙醇提取物,在绿色木霉、分枝犁头霉和黑曲霉真菌培养基27-30℃条件进行发酵1-6天,将发酵后的绞股蓝总提物冷冻干燥,用8-10倍量(v/w,mL/g)的80%乙醇超声提取2-4次,每次20-40min。将发酵绞股蓝乙醇提取液减压浓缩,干燥得到本发明所述的绞股蓝提取物。通过采用微生物转化的方法制备的绞股蓝提取物中活性成分的含量明显提高。The invention relates to a Gynostemma Gynostemma extract and a preparation method for fungal transformation thereof. The preparation method of the extract is as follows: take the Gynostemma pentaphyllum ethanol extract, and put it on the fungal culture medium of Trichoderma viride, Absidia cladoides and Aspergillus niger at 27-30°C Fermentation is carried out for 1-6 days, the total fermented Gynostemma pentaphyllum extract is freeze-dried, and ultrasonically extracted with 80% ethanol of 8-10 times the amount (v/w, mL/g) for 2-4 times, each time for 20-40 min. The fermented Gynostemma pentaphyllum ethanol extract is concentrated under reduced pressure and dried to obtain the Gynostemma pentaphyllum extract of the present invention. The content of active ingredients in the Gynostemma pentaphyllum extract prepared by adopting the method of microbial transformation is obviously increased.

Description

一种绞股蓝提取物及其真菌转化制备方法A kind of Gynostemma pentaphyllum extract and its fungal transformation preparation method

技术领域technical field

本发明涉及一种富含达木林A、达木林B、gypenoside L和gypenoside LI的绞股蓝(Gynostemmapentaphyllum)提取物,以及该提取物的真菌转化制备方法。The invention relates to a Gynostemma pentaphyllum extract rich in damulin A, damulin B, gypenoside L and gypenoside LI, and a method for preparing the extract through fungal transformation.

背景技术Background technique

皂苷类化合物是以C30骨架作为母核的糖苷,广泛存在于植物界中。根据碳骨架不同可分为三萜皂苷和甾体皂苷[1]。其中,三萜皂苷主要存在于五加科、豆科、远志科和葫芦科,甾体皂苷主要存在于薯蓣科、百合科和玄参科。此外,海星、海参等海洋生物中也存在皂苷类化合物。皂苷类成分具有复杂的物理化学性质(如具有发泡和乳化作用),因而也具有广泛的药理活性,如抗肿瘤、抗炎、抗微生物、抗糖尿病、抗氧化、免疫促进以及心血管和神经保护等作用[2-7]。Saponins are glycosides with a C30 skeleton as the core, and are widely found in the plant kingdom. According to different carbon skeletons, they can be divided into triterpene saponins and steroidal saponins [1]. Among them, triterpene saponins mainly exist in Araliaceae, Fabaceae, Polygalaceae and Cucurbitaceae, and steroidal saponins mainly exist in Dioscoreaceae, Liliaceae and Scrophulariaceae. In addition, saponins also exist in marine organisms such as starfish and sea cucumbers. Saponins have complex physicochemical properties (such as foaming and emulsifying effects), and thus also have a wide range of pharmacological activities, such as anti-tumor, anti-inflammatory, anti-microbial, anti-diabetic, anti-oxidation, immune promotion, and cardiovascular and neurological Protection and other functions [2-7].

皂苷具有许多不同的生物活性,如人参皂苷Rb1在C3和C20位均连有糖基,具有保护神经[8]、改善记忆作用[9]。而人参皂苷Rg3和Rh2,它们只在C3位连有糖基,具有较强的抗肿瘤活性[10,11]。前期研究表明,热处理绞股蓝产物中分离得到的绞股蓝皂苷gypenosideL、gypenoside LI、damulin A和damulin B具有较强的抑制非小细胞肺癌增殖作用[12]。但这四个化合物在绞股蓝原植物中含量甚微。因此,对于这些含量低的皂苷类活性成分的合理转化和结构修饰已成为当今药物研究的一个热点。Saponins have many different biological activities. For example, ginsenoside Rb1 has sugar groups at C3 and C20, which can protect nerves [8] and improve memory [9]. Ginsenosides Rg3 and Rh2, which only have sugar groups at the C3 position, have strong antitumor activity [10,11]. Previous studies have shown that the gypenosides gypenoside L, gypenoside LI, damulin A and damulin B isolated from heat-treated Gynostemma pentaphyllum products have a strong inhibitory effect on the proliferation of non-small cell lung cancer [12]. But the content of these four compounds in Gynostemma pentaphyllum is very small. Therefore, the rational transformation and structural modification of these low-content saponin active ingredients has become a hot spot in current pharmaceutical research.

绞股蓝为葫芦科(Cucurbitaceae)绞股蓝属(Gynostemma)绞股蓝Gynostemmapentaphyllum(Thunb.)Makino的全草[13],具有清热解毒,止咳祛痰等功能。由于绞股蓝中含有与人参相似的达玛烷类皂苷,又被冠予“南方人参”、“第二人参”的美誉[14]。Gynostemma pentaphyllum is the whole herb of Gynostemma pentaphyllum (Thunb.) Makino in Cucurbitaceae (Cucurbitaceae) Gynostemma Gynostemma pentaphyllum (Thunb.) Makino [13]. Because Gynostemma pentaphyllum contains dammarane saponins similar to ginseng, it has been dubbed "Southern ginseng" and "Second ginseng" [14].

利用微生物对有机化合物进行生物转化是获得化学合成方法难以得到的新类型结构的有效方法之一,微生物对三萜类化合物的区域选择性和立体选择性转化已被广泛研究[15,16]。参考文献:The biotransformation of organic compounds by microorganisms is one of the effective methods to obtain new types of structures that are difficult to obtain by chemical synthesis methods. The regioselective and stereoselective transformations of triterpenoids by microorganisms have been extensively studied [15,16]. references:

[1]Vincken J P,Heng L,de Groot A,et al.Saponins,classification and℃currence in the plantkingdom[J].Phyt℃hemistry,2007,68(3):275-297.[1] Vincken J P, Heng L, de Groot A, et al. Saponins, classification and °Currence in the plant kingdom[J]. Phyt °Chemistry, 2007, 68(3): 275-297.

[2]Petronelli A,Pannitteri G,Testa U.Triterpenoids as new promising anticancer drugs[J].Anticancer Drugs,2009,20(10):880-892.[2] Petronelli A, Pannitteri G, Testa U. Triterpenoids as new promising anticancer drugs [J]. Anticancer Drugs, 2009, 20(10): 880-892.

[3]Shin E M,Zhou H Y,Xu G H,et al.Anti-inflammatory activity of hispidol A25-methyl ether,a triterpenoid isolated from Ponciri Immaturus Fructus[J].Eur.J.Pharmacol,2010,627(1-3):318-324.[3]Shin E M, Zhou H Y, Xu G H, et al.Anti-inflammatory activity of hispidol A25-methyl ether, a triterpenoid isolated from Ponciri Immaturus Fructus[J].Eur.J.Pharmacol, 2010, 627( 1-3): 318-324.

[4]Yodsaoue O,Sonprasit J,Karalai C,et al.Diterpenoids and triterpenoids with potentialanti-inflammatory activity from the leaves of Aglaia odorata[J].Phyt℃hemistry,2012,76:83-91.[4] Yodsaoue O, Sonprasit J, Karalai C, et al. Diterpenoids and triterpenoids with potentialanti-inflammatory activity from the leaves of Aglaia odorata[J]. Phyt ° chemistry, 2012, 76: 83-91.

[5]Yadava R N,JharbadeJ.A new bioactive triterpenoid saponin from the seeds of Lactucascariola Linn[J].Nat.Prod.Res,2007,21(6):500-506.[5] Yadava R N, Jharbade J. A new bioactive triterpenoid saponin from the seeds of Lactucascariola Linn [J]. Nat. Prod. Res, 2007, 21(6): 500-506.

[6]Yoon S H,Han E J,Sung J H,et al.Anti-diabetic effects of compound K versus metforminversus compound K-metformin combination therapy in diabetic db/db mice[J].Biol.Pharm.Bull,2007,30(11):2196-2200.[6]Yoon S H, Han E J, Sung J H, et al.Anti-diabetic effects of compound K versus metforminversus compound K-metformin combination therapy in diabetic db/db mice[J].Biol.Pharm.Bull, 2007 , 30(11): 2196-2200.

[7]Kim Y A,Kong C S,Lee J I,et al.Evaluation of novel antioxidant triterpenoid saponins fromthe halophyte Salicornia herbacea[J].Bioorg.Med.Chem.Lett,2012,22(13):4318-4322.[7]Kim Y A, Kong C S, Lee J I, et al.Evaluation of novel antioxidant triterpenoid saponins from the halophyte Salicornia herbacea[J].Bioorg.Med.Chem.Lett,2012,22(13):4318-4322 .

[8]刘忞,张均田.人参皂甙Rb1和Rg1对原代培养大鼠海马神经细胞的保护作用[J].药学学报,1995,30(9):674-678.[8] Liu Min, Zhang Juntian. Protective effects of ginsenosides Rb1 and Rg1 on primary cultured rat hippocampal neurons [J]. Acta Pharmaceutica Sinica, 1995, 30(9): 674-678.

[9]Wang Q,Sun L H,Jia W,et al.Comparison of ginsenosides Rg1and Rb1for their effects onimproving scopolamine-induced learning and memory impairment in mice[J].Phytother.Res,2010,24(12):1748-1754.[9] Wang Q, Sun L H, Jia W, et al. Comparison of ginsenosides Rg1 and Rb1 for their effects on improving scopolamine-induced learning and memory impairment in mice[J]. Phytother. Res, 2010, 24(12): 1748- 1754.

[10]Jiang J W,Chen X M,Chen X H,et al.Ginsenoside Rg3inhibit hepat℃ellular carcinomagrowth via intrinsic apoptotic pathway[J].World J.Gastroenterol,2011,17(31):3605-3613.[10] Jiang J W, Chen X M, Chen X H, et al.Ginsenoside Rg3inhibit hepat°cellular carcinoma growth via intrinsic apoptotic pathway[J].World J.Gastroenterol, 2011, 17(31): 3605-3613.

[11]Li B,Zhao J,Wang C Z,et al.Ginsenoside Rh2induces apoptosis and paraptosis-like celldeath in colorectal cancer cells through activation of p53[J].Cancer Lett,2011,301(2):185-192.[11] Li B, Zhao J, Wang C Z, et al. Ginsenoside Rh2induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53[J]. Cancer Lett, 2011, 301(2): 185-192.

[12]Piao X L,Wu Q,Yang J,et al.Dammarane-type saponins from heat-pr℃essed Gynostemmapentaphyllum show fortified activity against A549cells[J].Arch Pharn Res,2013,36(7):874-879.[12]Piao X L, Wu Q, Yang J, et al.Dammarane-type saponins from heat-pr Cessed Gynostemmapentaphyllum show fortified activity against A549cells[J].Arch Pharn Res, 2013, 36(7): 874-879 .

[13]梁启成,钟鸣,中国状药学[M],广西民族出版社,2005.[13] Liang Qicheng, Zhong Ming, Chinese Pharmacology [M], Guangxi Minzu Publishing House, 2005.

[14]张涛,袁弟顺.中国绞股蓝种质资源研究进展[J].云南农业大学学报,2009,24(3):459-469.[14] Zhang Tao, Yuan Dishun. Research progress on germplasm resources of Gynostemma pentaphyllum in China [J]. Journal of Yunnan Agricultural University, 2009, 24(3): 459-469.

[15]Huang F X,Yang W Z,Ye F,et al.Microbial trahsformation of ursolic acid bySyncephalastrum racemosum(Cohn)Schroter AS3.264[J].Phyt℃hemistry,2012,82:56-60.[15] Huang F X, Yang W Z, Ye F, et al. Microbial trauma of ursolic acid by Syncephalastrum racemosum (Cohn) Schroter AS3.264 [J]. Phyt ° chemistry, 2012, 82: 56-60.

[16]Dong A,Ye M,Guo H,et al.Microbial transformation of ginsenoside Rb1by Rhizopusstolonifer and Curvularia lunata[J].Biotechnol.Lett,2003,25(4):339-344.[16] Dong A, Ye M, Guo H, et al. Microbial transformation of ginsenoside Rb1by Rhizopusstlonifer and Curvularia lunata[J]. Biotechnol. Lett, 2003, 25(4): 339-344.

发明内容Contents of the invention

本发明的目的在于提出一种富含达木林A(damulin A)、达木林B(damulin B)、gypenosideL和gypenoside LI的绞股蓝提取物,该提取物的制备方法,以及该提取物在制备治疗肿瘤药物中的用途。通过采用真菌转化的方法制备的绞股蓝提取物中抗肿瘤活性成分的含量明显提高,进而增强了本发明的绞股蓝提取物治疗肿瘤的效果。The object of the present invention is to propose a kind of Jiaogulan extract rich in damulin A (damulin A), damulin B (damulin B), gypenoside L and gypenoside LI, the preparation method of the extract, and the use of the extract in preparing and treating tumors Uses in medicine. The content of anti-tumor active components in the Gynostemma pentaphyllum extract prepared by adopting the fungal transformation method is obviously increased, thereby enhancing the effect of the Gynostemma pentaphyllum extract of the present invention on treating tumors.

本发明的绞股蓝提取物中含有以下化合物:The Gynostemma pentaphyllum extract of the present invention contains the following compounds:

Figure BSA0000100396980000031
Figure BSA0000100396980000031

本发明的绞股蓝提取物的制备方法如下:The preparation method of Gynostemma pentaphyllum extract of the present invention is as follows:

取绞股蓝乙醇提取物,在真菌培养基27-31℃条件进行发酵1-10天,将发酵后的绞股蓝总提物用等体积正丁醇萃取1-6次,减压浓缩,干燥得到本发明所述的绞股蓝提取物,所述的真菌选自绿色木霉、分枝犁头霉和黑曲霉。Take the ethanol extract of Gynostemma pentaphyllum, ferment it for 1-10 days in the fungal culture medium at 27-31°C, extract the total fermented Gynostemma pentaphyllum extract with an equal volume of n-butanol for 1-6 times, concentrate under reduced pressure, and dry to obtain the present invention. For the Gynostemma pentaphyllum extract, the fungus is selected from Trichoderma viride, Absidia cladoides and Aspergillus niger.

优选的制备方法如下:The preferred preparation method is as follows:

取绞股蓝乙醇提取物,在真菌培养基28-30℃条件进行发酵2-8天,将发酵后的绞股蓝总提物用等体积正丁醇萃取2-4次,减压浓缩,干燥得到本发明所述的绞股蓝提取物,所述的真菌选自绿色木霉、分枝犁头霉和黑曲霉。Take the ethanol extract of Gynostemma pentaphyllum, ferment it for 2-8 days under the condition of 28-30°C in the fungal culture medium, extract the total fermented Gynostemma pentaphyllum extract with an equal volume of n-butanol for 2-4 times, concentrate under reduced pressure, and dry to obtain the present invention For the Gynostemma pentaphyllum extract, the fungus is selected from Trichoderma viride, Absidia cladoides and Aspergillus niger.

进一步优选的制备方法如下:A further preferred preparation method is as follows:

取绞股蓝乙醇提取物,在真菌培养基28℃条件进行发酵7天,将发酵后的绞股蓝总提物用等体积正丁醇萃取3次,减压浓缩,干燥得到本发明所述的绞股蓝提取物,所述的真菌选自绿色木霉、分枝犁头霉和黑曲霉。Take the ethanol extract of Gynostemma pentaphyllum, ferment it for 7 days under the condition of 28°C in the fungal culture medium, extract the total Gynostemma pentaphyllum extract after fermentation with an equal volume of n-butanol for 3 times, concentrate under reduced pressure, and dry to obtain the Gynostemma pentaphyllum extract of the present invention , the fungi are selected from Trichoderma viride, Absidia cladoides and Aspergillus niger.

所述的绞股蓝乙醇提取物的制备方法为:取绞股蓝用5-10倍量(v/w,mL/g)的60-95%乙醇回流提取1-8次,每次1-5h,浓缩即得;The preparation method of the ethanol extract of Gynostemma pentaphyllum is as follows: take Gynostemma pentaphyllum and use 5-10 times the amount (v/w, mL/g) of 60-95% ethanol to reflux extract for 1-8 times, each time for 1-5h, and concentrate have to;

进一步优选:取绞股蓝用8倍量(v/w,mL/g)的80%乙醇回流提取3次,每次2h,浓缩即得。More preferably: Gynostemma pentaphyllum is extracted with 8 times the amount (v/w, mL/g) of 80% ethanol under reflux for 3 times, each time for 2 hours, and then concentrated.

本发明通过运用LCMS-IT-TOF技术手段,根据文献,鉴定了所制备的绞股蓝提取物中的4个有效成分:达木林A(damulin A)、达木林B(damulin B)、gypenoside L和gypenosideLI。并利用HPLC-MS分析方法,对该提取物中的各有效成分进行了含量变化分析。其中:The present invention identifies 4 active ingredients in the prepared Gynostemma pentaphylla extract according to the literature by using LCMS-IT-TOF technical means: Damulin A (damulin A), Damulin B (damulin B), gypenoside L and gypenoside LI . And using the HPLC-MS analysis method, the content change analysis of each active ingredient in the extract was carried out. in:

所述的化合物通过绿色木霉、分枝犁头霉和黑曲霉真菌发酵,含量均提高。The compound is fermented by Trichoderma viride, Absidia cladoides and Aspergillus niger, and the content of the compound is all increased.

所述绞股蓝提取物中有效成分的分离及鉴定如下:The separation and identification of active ingredients in the Gynostemma pentaphyllum extract are as follows:

用硅胶柱色谱方法,洗脱液二氯甲烷-甲醇的比例从10∶1至6∶1洗脱。With silica gel column chromatography, the eluent was eluted in a dichloromethane-methanol ratio from 10:1 to 6:1.

上述二氯甲烷-甲醇(6∶1)洗脱液通过LCMS-IT-TOF技术手段,根据文献,最终被鉴定为绞股蓝皂苷gypenosdie L、gypenoside LI、达木林A、达木林B。The above methylene chloride-methanol (6:1) eluate was finally identified as gypenoside gypenosdie L, gypenoside LI, Damulin A, and Damulin B through LCMS-IT-TOF technical means and according to the literature.

由于达木林A、达木林B、gypenoside L、gypenoside LI对于肺癌、胃癌、卵巢癌、乳腺癌和白血病细胞均具有较强的抑制作用,因此在本发明中,我们还提供了本发明制备得到的绞股蓝提取物在制备治疗肿瘤药物中的用途。Since Damulin A, Damulin B, gypenoside L, and gypenoside LI all have strong inhibitory effects on lung cancer, gastric cancer, ovarian cancer, breast cancer and leukemia cells, so in the present invention, we also provide the prepared Use of Jiaogulan extract in preparing medicines for treating tumors.

具体实施方式Detailed ways

实施例1提取物的制备实验Preparation experiment of embodiment 1 extract

我们比较了几种不同的制备方法制备得到的提取物,并测定了其中达木林A、达木林B、gypenoside L、gypenoside LI四个化合物的含量。结果如下:We compared the extracts prepared by several different preparation methods, and determined the content of four compounds, Damulin A, Damulin B, gypenoside L, and gypenoside LI. The result is as follows:

1.发酵前绞股蓝醇提物的制备1. Preparation of Gynostemma pentaphylla alcoholic extract before fermentation

取绞股蓝用8倍量(v/w,mL/g)的80%乙醇回流提取3次,每次2h,浓缩,得到绞股蓝乙醇提取物;在绿色木霉培养基中,直接冷冻干燥,得到发酵前绞股蓝醇提物。Take Gynostemma pentaphyllum and use 8 times the amount (v/w, mL/g) of 80% ethanol to reflux extract 3 times, each time for 2 hours, concentrate to obtain Gynostemma pentaphyllum ethanol extract; directly freeze-dry in Trichoderma viride culture medium to obtain fermented Alcoholic extract of Gynostemma pentaphyllum.

2.绞股蓝醇提物的绿色木霉、分枝犁头霉和黑曲霉真菌发酵产物的制备(本发明制备的绞股2. the preparation of Trichoderma viride, Absidia cladoides and Aspergillus niger fungal fermentation product of Gynostemma pentaphyllum ethanol extract (Gynostemma pentaphyllum prepared by the present invention 蓝提取物)blue extract)

取绞股蓝用8倍量(v/w,mL/g)的80%乙醇回流提取3次,每次2h,浓缩,得到绞股蓝乙醇提取物,在绿色木霉、分枝犁头霉和黑曲霉真菌培养基中,29℃发酵7天,冷冻干燥得到绞股蓝醇提物的发酵产物。Take Gynostemma pentaphyllum and use 8 times the amount (v/w, mL/g) of 80% ethanol to reflux extract 3 times, each time for 2h, concentrate to obtain Gynostemma pentaphyllum ethanol extract, which can be used in Trichoderma viride, Absidia cladoides and Aspergillus niger fungi In the culture medium, ferment at 29 DEG C for 7 days, and freeze-dry to obtain the fermentation product of the alcoholic extract of Gynostemma pentaphyllum.

表1不同提取物中达木林A、达木林B、gypenoside L、gypenoside LI的峰面积变化Table 1 The peak area changes of Damulin A, Damulin B, gypenoside L, and gypenoside LI in different extracts

Figure BSA0000100396980000051
Figure BSA0000100396980000051

利用HPLC-MS分析方法,对发酵前绞股蓝醇提物和绞股蓝醇提物的发酵产物进行含量比较。Using the HPLC-MS analysis method, the content of the alcoholic extract of Gynostemma pentaphyllum before fermentation and the fermentation product of Gynostemma pentaphyllum alcoholic extract were compared.

结果表明,如表1所示,本发明保护的技术方案得到的绞股蓝醇提物的发酵产物(本发明制备的绞股蓝提取物)中绞股蓝皂苷达木林A、达木林B、gypenoside L、gypenoside LI的含量提高。具体而言,雅致小克银汉霉、长枝木霉和梅林青霉转化效果较差,其中经雅致小克银汉霉转化后达木林A、达木林B、gypenoside L、gypenoside LI含量均降低;而长枝木霉和梅林青霉发酵后均未检测到四中活性成分。The results show that, as shown in Table 1, in the fermentation product of the Gynostemma pentaphyllum ethanol extract obtained by the technical scheme protected by the present invention (the Gynostemma pentaphyllum extract prepared by the present invention), the content of Gypenoside Damulin A, Damulin B, gypenoside L, and gypenoside LI content increased. Specifically, the transformation effects of C. elegans, Trichoderma longibrachiae, and Penicillium melini were poor, and the contents of Damulin A, Damulin B, gypenoside L, and gypenoside LI all decreased after being transformed by Elegantia xiaograms; while None of the four active ingredients were detected after fermentation by Trichoderma longibrachiae and Penicillium melini.

反之,绿色木霉能够使gypenoside L和gypenoside LI含量增加,而分枝犁头霉和黑曲霉能够使四种有效成分的含量均得到显著的提高。On the contrary, Trichoderma viride can increase the content of gypenoside L and gypenoside LI, while Absidia cladoides and Aspergillus niger can significantly increase the content of the four active ingredients.

Claims (9)

1.一种绞股蓝提取物,其特征在于,采用微生物发酵的方法制备得到,所述的微生物为真菌。1. a Gynostemma pentaphyllum extract, is characterized in that, adopts the method for microbial fermentation to prepare, and described microorganism is fungus. 2.一种绞股蓝提取物,其特征在于,所述的绞股蓝提取物的制备方法包括以下步骤:取绞股蓝乙醇提取物,在真菌培养基27-31℃条件进行发酵1-10天,将发酵后的绞股蓝总提物用等体积正丁醇萃取1-6次,减压浓缩,干燥得到绞股蓝提取物,所述的真菌选自绿色木霉、分枝犁头霉和黑曲霉;所述的绞股蓝提取物中含有以下化合物:2. An extract of Gynostemma pentaphyllum, it is characterized in that, the preparation method of described Gynostemma pentaphyllum extract comprises the following steps: get the Gynostemma pentaphyllum ethanol extract, carry out fermentation 1-10 days at 27-31 ℃ of conditions of fungal culture medium, after fermenting The total extract of Gynostemma pentaphylla is extracted 1-6 times with an equal volume of n-butanol, concentrated under reduced pressure, and dried to obtain Gynostemma pentaphyllum extract, and the fungus is selected from Trichoderma viride, Absidia cladoides and Aspergillus niger; The extract contains the following compounds: 3.如权利要求2所述的绞股蓝提取物,其特征在于,所述的绞股蓝提取物的制备方法包括以下步骤:取绞股蓝乙醇提取物,在真菌培养基28-30℃条件进行发酵2-8天,将发酵后的绞股蓝总提物用等体积正丁醇萃取2-4次,减压浓缩,干燥。3. Gynostemma pentaphyllum extract as claimed in claim 2, is characterized in that, the preparation method of described Gynostemma pentaphyllum extract comprises the following steps: get Gynostemma pentaphyllum ethanol extract, carry out fermentation 2-8 in fungal culture medium 28-30 ℃ condition day, the fermented Gynostemma pentaphylla total extract was extracted 2-4 times with an equal volume of n-butanol, concentrated under reduced pressure, and dried. 4.如权利要求2所述的绞股蓝提取物,其特征在于,所述的绞股蓝提取物的制备方法包括以下步骤:取绞股蓝乙醇提取物,在真菌培养基28℃条件进行发酵7天,将发酵后的绞股蓝总提物用等体积正丁醇萃取3次,减压浓缩,干燥。4. Gynostemma pentaphyllum extract as claimed in claim 2, is characterized in that, the preparation method of described Gynostemma pentaphyllum extract comprises the following steps: get Gynostemma pentaphyllum ethanol extract, ferment 7 days at 28 ℃ of conditions of fungal culture medium, ferment The final Gynostemma pentaphyllum extract was extracted three times with an equal volume of n-butanol, concentrated under reduced pressure, and dried. 5.如权利要求2-4任一项所述的绞股蓝提取物,其特征在于,所述的绞股蓝乙醇提取物的制备方法为:取绞股蓝用5-10倍量(v/w,mL/g)的60-95%乙醇回流提取1-8次,每次1-5h,浓缩即得。5. the Gynostemma extract as described in any one of claim 2-4, is characterized in that, the preparation method of described Gynostemma ethanol extract is: get Gynostemma with 5-10 times of amount (v/w, mL/g ) with 60-95% ethanol for reflux extraction for 1-8 times, each time for 1-5h, and then concentrate. 6.如权利要求2-4任一项所述的绞股蓝提取物,其特征在于,所述的绞股蓝乙醇提取物的制备方法为:取绞股蓝用8倍量(v/w,mL/g)的80%乙醇回流提取3次,每次2h,浓缩即得。6. the Gynostemma extract as described in any one of claim 2-4, is characterized in that, the preparation method of described Gynostemma ethanol extract is: get Gynostemma with 8 times of amount (v/w, mL/g) Reflux extraction with 80% ethanol for 3 times, 2 hours each time, and concentrate. 7.如权利要求2-4任一项所述的绞股蓝提取物,其特征在于,所述化合物占绞股蓝提取物的重量比为:damulin A18-30mg/g、damulin B5.5-30mg/g、gypenoside L5-20mg/g、gypenosideLI2.5-10mg/g。7. the Gynostemma extract as described in any one of claim 2-4, it is characterized in that, the weight ratio that described compound accounts for Gynostemma extract is: damulin A18-30mg/g, damulin B5.5-30mg/g, gypenoside L5-20mg/g, gypenoside LI2.5-10mg/g. 8.权利要求2-7任一项所述的绞股蓝提取物在制备治疗癌症药物中的应用。8. The application of the Gynostemma pentaphyllum extract described in any one of claims 2-7 in the preparation of a drug for treating cancer. 9.如权利要求8所述的应用,其特征在于,所述的癌症选自:肺癌、胃癌、卵巢癌、乳腺癌或白血病。9. The application according to claim 8, wherein the cancer is selected from lung cancer, gastric cancer, ovarian cancer, breast cancer or leukemia.
CN201410019158.3A 2014-01-16 2014-01-16 Gynostemma pentaphylla extract and fungus transformation preparation method thereof Pending CN103720740A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410019158.3A CN103720740A (en) 2014-01-16 2014-01-16 Gynostemma pentaphylla extract and fungus transformation preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410019158.3A CN103720740A (en) 2014-01-16 2014-01-16 Gynostemma pentaphylla extract and fungus transformation preparation method thereof

Publications (1)

Publication Number Publication Date
CN103720740A true CN103720740A (en) 2014-04-16

Family

ID=50445202

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410019158.3A Pending CN103720740A (en) 2014-01-16 2014-01-16 Gynostemma pentaphylla extract and fungus transformation preparation method thereof

Country Status (1)

Country Link
CN (1) CN103720740A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108179169A (en) * 2018-03-23 2018-06-19 娄志春 A kind of method that microbe transformation method prepares damulin A
WO2019178980A1 (en) * 2018-03-23 2019-09-26 娄志春 Method for preparing gynostemma pentaphylla makino saponin lvi, xlvi, l, li, damulin a or damulin b

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102603849A (en) * 2012-02-10 2012-07-25 厦门华侨亚热带植物引种园 Gynostemma pentaphylla secondary saponin, preparation method and applications thereof
CN103169725A (en) * 2013-01-29 2013-06-26 中央民族大学 Gynostemma pentaphyllum extract and application thereof in preparation of medicament for treating tumor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102603849A (en) * 2012-02-10 2012-07-25 厦门华侨亚热带植物引种园 Gynostemma pentaphylla secondary saponin, preparation method and applications thereof
CN103169725A (en) * 2013-01-29 2013-06-26 中央民族大学 Gynostemma pentaphyllum extract and application thereof in preparation of medicament for treating tumor

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108179169A (en) * 2018-03-23 2018-06-19 娄志春 A kind of method that microbe transformation method prepares damulin A
CN108179169B (en) * 2018-03-23 2018-11-23 江苏天芳健康科技有限公司 A kind of method that microbe transformation method prepares damulin A
WO2019178980A1 (en) * 2018-03-23 2019-09-26 娄志春 Method for preparing gynostemma pentaphylla makino saponin lvi, xlvi, l, li, damulin a or damulin b

Similar Documents

Publication Publication Date Title
Jin et al. Effect of white, red and black ginseng on physicochemical properties and ginsenosides
CN103223018B (en) Flos Osmanthi Fragrantis polyphenol extract and its production and use
CN103169725A (en) Gynostemma pentaphyllum extract and application thereof in preparation of medicament for treating tumor
CN104825500A (en) Ganoderma leucocontextum extract, extracting method thereof and application thereof
CN103908486A (en) Preparing method of gynostemma pentaphyllum extraction product rich in gypenosides
CN102247420A (en) Preparation method and application of eclipta extract
CN108003214A (en) A kind of saponin compound and its methods and applications extracted from the rhizoma bolbostemmae
CN104788406B (en) Shaggy-fruited dittany phenolic acid B and preparation method thereof and the purposes of shaggy-fruited dittany phenolic acid B
CN102293789A (en) Method for extracting triterpenoids from ganoderma lucidum sporocarp
CN106317156B (en) A kind of penta hydroxy group diones cucurbit alkane type triterpenoid and its preparation method and purposes
CN107446014B (en) Dulong Paris polyphylla ethanol extract and its application in pharmacy separate and identification method with its chemical component
CN103720740A (en) Gynostemma pentaphylla extract and fungus transformation preparation method thereof
CN104844675A (en) Ganoderma leucocontextum triterpenoid, medicinal composition and application thereof
Jin et al. Biotransformation of ginsenosides (ginseng saponins)
CN103006741B (en) Extract of anti-tumor effective components of Tinglizi and its preparation method and application
CN102416025B (en) Flammulina velutipes antineoplastic active ingredient extract and its preparation method and use
CN102028722B (en) Extract of effective parts of total saponins in pterocephalus hookeri as well as preparation method and application thereof
CN104910172B (en) Five kinds of talan trimer preparation methods and its application
CN109468359B (en) Ginsenoside Rk6Preparation method of (1)
Cho et al. Three new ginsenosides from the heat-processed roots of Panax ginseng
CN103027932A (en) Cortex periplocae anti-tumor effective component extractive as well as preparation method and application thereof
CN102670935B (en) A method for extracting total saponins from scallions
CN102764320A (en) Psychotria sp. extract, and preparation method and antineoplastic application thereof
CN107513084A (en) White crane rattan alkali and its extracting method and application thereof
CN103509077B (en) Triterpene saponin componds and its production and use

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140416